WINNIPEG, MB / ACCESS Newswire / April 22, 2025 / Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH)(OTC PINK:MCUJF), a company focused on the development and commercialization of pharmaceuticals ...

and in one patient a bolus of tirofiban was given on the table followed by 12 hours infusion (see table 1). The post-procedural antiplatelet regime consisted of ticagrelor 90 mg twice daily and ...